The singer and flutist hopped on Instagram Live to break down how she lost weight and what she does to ensure she focuses on ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

The virtual nutrition care startup just raised a $70 million Series B funding round, and it's profitable, BI has learned ...

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its oral weight-loss treatment. ...

Lizzo has revealed how she dropped a whopping 16% of her body fat during a TikTok livestream on Tuesday — months after ...

Startup Brellium built an artificial-intelligence-powered solution that helps providers automate clinical quality and payer ...

Lizzo is determined to rid herself of her past, even if that means changing everything about herself that made her so popular originally - and now those closest to her are concerned.

Dario Perkins, an economist at macro research firm TS Lombard, interpreted that the market would welcome Trump's (reluctant) vote of confidence, but the damage he has done to the Fed's independence is ...

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic headwinds. A key catalyst was last week’s announcement from rival Eli Lilly LLY, ...

The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week.